Among patients with mild obstructive sleep apnea, quality of life is improved at 3 months for those receiving continuous positive airway pressure therapy plus standard care compared with standard care alone.
Even after long-term continuous positive airway pressure (CPAP) use, intensive telemedicine support can be used to help optimize CPAP adherence in patients with obstructive sleep apnea.
In large trial and literature review, benefit seen for depression but not anxiety symptoms.
A mean nocturnal respiratory rate of ≥16 breaths per minute was an independent predictor of long-term cardiovascular and all-cause mortality among community-dwelling older men and women.
Increased odds ratios for cancer observed in different categories of OSA for women, not men.
Patients with untreated obstructive sleep apnea have been shown to have numerous cognitive disturbances, which can lead to poor work performance, work errors, and poor quality of life.
Short sleep duration is associated with daytime sleepiness, while obstructive sleep apnea is associated with obesity, hypertension, and dyslipidemia.
In addition to known predictors of apnea, diabetes-related foot disease, insulin treatment up risk.
Odds of sleep apnea increase with increase in nitrogen dioxide exposure, PM2.5 exposure.
Among OSA patients, risk for developing gout is highest 1 to 2 years after the index date.
